Clinical Trials Browser

OTHER_GOV × Ovarian Neoplasms × Interleukin-2 × Clear all

NCT03412526 2019-04-04

Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian

Phase 2 Unknown

Ovarian Neoplasms